New York, USA
Joined August 2022
Maximilian Schaefer retweeted
CytoVI is finally out in @naturemethods! We introduce our first deep generative model built for immunologists working with cytometry data to mitigate some of the most pressing limitations of the technology! Grateful for the fantastic collaboration with @YosefLab & @IdoAmitLab
Different panels. Different technologies. Can we bring flow cytometry into biology’s AI revolution? Introducing CytoVI in @NatureMethods: linking cytometry & single-cell genomics to predict missing markers and reveal disease-associated cell states.🧵(1/15) doi.org/10.1038/s41592-026-0…
11
16
1
55
5,411
A lot of cool tech went into this one, including Perturb-Map Multi-modal—a spatial CRISPR screen with dual Xenium-CyCIF readout, linking genetic perturbations directly to spatial immune phenotypes. (2/n)
2
1
4
159
I was such a blast to work on this project and I learned so much! Thank you to all the coauthors especially @ChiaraFalcomata and Bhavya Singh and Divya Chhamalwan! (3/n)
1
3
72
🥳🥳
Pancreatic tumors are highly heterogeneous and immunosuppressive. But is immune resistance imposed across the whole tumor - or built locally by distinct cancer-cell states? I’m incredibly excited to share our new paper, now out in @Nature! 🎉 doi.org/10.1038/s41586-026-1… (1/7)
1
7
270
Maximilian Schaefer retweeted
Cancer-derived SERPINE1 and SERPINB2 are local spatial organizers of immune suppression @Nature @IcahnMountSinai @ChiaraFalcomata @SinaiImmunol nature.com/articles/s41586-0…
16
56
3,447
Maximilian Schaefer retweeted
Excited to share our new study @ScienceMagazine by the fantastic Raphael Mattiuz and @jboumelha @SinaiImmunol showing how DC build and sustain tertiary lymphoid structures in cancer. A major step toward enhancing anti-tumor immunity (1/2) science.org/doi/10.1126/scie…
14
99
6
368
35,496
Congrats Flo 🎉 So exciting for the science that will come out of your lab!!
hello world. Excited to launch the Ingelfinger Lab account! We’re a young lab in Germany’s Black Forest tackling key questions in immunology with innovative single-cell technologies. Follow us for updates on systems immunology, machine learning & translational oncology. fi
1
2
151
Maximilian Schaefer retweeted
hello world. Excited to launch the Ingelfinger Lab account! We’re a young lab in Germany’s Black Forest tackling key questions in immunology with innovative single-cell technologies. Follow us for updates on systems immunology, machine learning & translational oncology. fi
4
8
3
42
11,141
Maximilian Schaefer retweeted
#ScienceSaturday ❓ Why do some cancers resist immunotherapy? ➡️ A recent study in Nature found that certain cancers can “trick” the body’s immune system. They do this by changing how cells in the bone marrow develop. These changes cause more immune cells called macrophages to form — but these macrophages actually block the immune system from attacking the tumor. ➡️ Lung cancers cause this change by stressing cells in a way that activates a protein called NRF2. This reprogramming creates macrophages that protect the tumor instead of fighting it. ➡️ The researchers found that blocking NRF2, through drugs or genetic changes, lowered these protective macrophages, boosted immune cell activity and made immunotherapy work better. This suggests a new way to improve treatments for cancers that usually resist immunotherapy. 🌟 Congratulations to senior author Miriam Merad of the Icahn School of Medicine at Mount Sinai, and collaborators at Institut Gustave Roussy, Harvard Medical School and others for advancing this critical work. @MiriamMerad @SinaiImmunol @IcahnMountSinai
7
77
5
316
25,433
Big congrats, Flo! Fantastic new tool to analyze high-dimensional flow data. @FlorianIngelfi1 @IdoAmitLab @YosefLab
🚨 New preprint! Generative modeling comes to cytometry. Meet CytoVI — a deep generative model from the @YosefLab & @IdoAmitLab for antibody-based single-cell technologies (flow, mass cytometry, CITE-seq). doi.org/10.1101/2025.09.07.6… 🧵👇
1
3
286
Thrilled our Perspective in @NatureAging is out! With @MatthewD_Park et al., we spotlight how aging reshapes RTMs and skews myelopoiesis–with consequences for healthy aging and cancer @MiriamMerad
3
273
New preprint out! 🚀Spearheaded by @ChiaraFalcomata we could show how pancreatic cancer cells evade the immune system by modulating their TME with the extracellular factors Serpine1 (PAI-1) and Serpinb2 (PAI-2)! #PertrubMap #PDAC
🚨 Our new #preprint is out! doi.org/10.1101/2025.06.11.6… We used #PerturbMap spatial functional genomics in pancreatic cancer to track tumor clone dynamics and uncover how extracellular factors like Serpine1 and Serpinb2 drive immune evasion. 🧵 (1/8)
1
5
590
Maximilian Schaefer retweeted
So excited to share our new paper out in @Nature led by the fabulous @AnaisElewaut and @guillemxtivill providing mechanistic insights into anti-tumor immunity and why it may fail in so many patients! Sky-torial on @obenaufa.bsky.social rdcu.be/d1F7s
#Immunotherapy has transformed #cancer treatment, but some cancers evade immune defenses, causing resistance. @obenaufa's lab has discovered how inflammatory monocytes—a type of immune cell—can reactivate cancer-killing T cells within tumors. Read more: imp.ac.at/news/article/a-tur…
7
19
3
69
7,311
Maximilian Schaefer retweeted
Another @preprintclub Journal Club by Zi Yan Chen & @nkg2d1 @ImmunologyUofT discusses @biorxivpreprint by @VillarVesga et al. @BecherLab @SarahMundt5 showing that monocyte-derived cells in CNS produce mitochondrial ROS to promote neuroinflammation bit.ly/495E7HP
1
8
11
3,244
As science twitter is moving to where the sky is blue: bsky.app/profile/mmschaefer.…
2
94
Fantastic @SinaiImmunol retreat on neuroimmunology–neuron-immune/immune–neuron interactions #CGRP #TRPV1 Thanks for organizing @itchdoctor @michel_enamorad @MiriamMerad
1
8
668